Literature DB >> 20590683

Sizing up pharmacotherapy for obesity.

Michael A Valentino1, Andre Terzic, Scott A Waldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20590683      PMCID： PMC2898887          DOI： 10.1111/j.1752-8062.2010.00191.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  30 in total

1.  Are health care professionals advising obese patients to lose weight?

Authors:  D A Galuska; J C Will; M K Serdula; E S Ford
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

Review 2.  Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.

Authors:  C J de Souza; B F Burkey
Journal:  Curr Pharm Des       Date:  2001-09       Impact factor: 3.116

3.  Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.

Authors:  P J King; P S Widdowson; H N Doods; G Williams
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

4.  Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.

Authors:  Adesh K Jain; Roy A Kaplan; Kishore M Gadde; Thomas A Wadden; David B Allison; Edwin R Brewer; Robert A Leadbetter; Nathalie Richard; Barbara Haight; Brenda D Jamerson; Kathleen S Buaron; Alan Metz
Journal:  Obes Res       Date:  2002-10

5.  Beneficial effect of diazoxide in obese hyperinsulinemic adults.

Authors:  R Alemzadeh; G Langley; L Upchurch; P Smith; A E Slonim
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

6.  Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

Authors:  James W Anderson; Frank L Greenway; Ken Fujioka; Kishore M Gadde; James McKenney; Patrick M O'Neil
Journal:  Obes Res       Date:  2002-07

7.  Adipose tissue mass can be regulated through the vasculature.

Authors:  Maria A Rupnick; Dipak Panigrahy; Chen-Yu Zhang; Susan M Dallabrida; Bradford B Lowell; Robert Langer; M Judah Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma.

Authors:  Frédéric Picard; Martin Kurtev; Namjin Chung; Acharawan Topark-Ngarm; Thanaset Senawong; Rita Machado De Oliveira; Mark Leid; Michael W McBurney; Leonard Guarente
Journal:  Nature       Date:  2004-06-02       Impact factor: 49.962

9.  Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene.

Authors:  K Nonogaki; A M Strack; M F Dallman; L H Tecott
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

10.  Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial.

Authors:  Katie Wynne; Adrian J Park; Caroline J Small; Michael Patterson; Sandra M Ellis; Kevin G Murphy; Alison M Wren; Gary S Frost; Karim Meeran; Mohammad A Ghatei; Stephen R Bloom
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461
View more
  2 in total

1.  Chronic diseases: the emerging pandemic.

Authors:  Andre Terzic; Scott Waldman
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

2.  Antiobesity strategy targets energy economy safeguards.

Authors:  Michel Vivaudou; André Terzic
Journal:  Mol Ther       Date:  2015-04       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.